Human embryo editing against disease is unsafe and unproven — despite rosy predictions

Shai Carmi (), Henry T. Greely () and Kevin J. Mitchell ()

Nature, 2025, vol. 637, issue 8046, 554-556

Abstract: Mathematical modelling suggests that it is theoretically possible to reduce risk of common diseases using heritable genome editing. Scientists argue that the technology involves considerable risk and uncertain benefits.

Keywords: CRISPR-Cas9 genome editing; Ethics (search for similar items in EconPapers)
Date: 2025
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/d41586-024-04105-7 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:637:y:2025:i:8046:d:10.1038_d41586-024-04105-7

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/d41586-024-04105-7

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().